Only a few viral infections can be preemptively addressed and C19 strain which are mutating by the minute, is definitely not one of them at this stage, especially via a preemptive nasal cavity approach!!!! This company will be sued to death, if this product does not work!!!!! Hence until clinically proven, this is deemed Disallowed!!!!
'Global patent' & the pending patent is already owned by the company- don't even get me started!!!!!
Run, while you still can!!!!!!!!
Only a few viral infections can be preemptively addressed and...
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add HCT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.394M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 179137 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 282891 | 2 |
View Market Depth
| Last trade - 16.12pm 05/07/2024 (20 minute delay) ? |
| HCT (ASX) Chart |
Day chart unavailable